Obesity, metabolic complications and the menopause: an opportunity for prevention

References

• World Health Organization. Obesity – Preventing and Managing the Global Epidemic: Report of a WHO Expert CommitteeGeneva: World Health Organization, 1998
   Google Scholar
• Benjamin SM, Valdez R, Geiss LS, Rolka DB, Venkat Narayan KM. Estimated number of adults with prediabetes in the US in 2000: opportunities for prevention. Diabetes Care 2003;26:645–649
   PubMed Web of Science ®Google Scholar
• Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999–2004. JAMA 2006;295:1549–1555
   PubMed Web of Science ®Google Scholar
• Ausdiab 2005 follow up Study Report available at http://www.diabetes.com.au/pdf/AUSDIAB_Report_Final.pdf
   Google Scholar
• Brown W, Byles J, Carrigan G, et al Trends in women's health: Results from the ALSWH – priority conditions, risk factors and health behaviours. Report prepared for The Australian Government Department of Health & Ageing 2006. Available at http://www.alswh.org.au/Reports/OtherReportsPDF/MajorReportAOct2006.pdf
   Google Scholar
• Consensus Development Conference on Insulin Resistance. American Diabetes Association. Diabetes Care 1998;21:310–314
   PubMedGoogle Scholar
• Diamanti-Kandarakis E, Kouli CR, Bergiele AT, et al A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 1999;84:4006–4011
   PubMed Web of Science ®Google Scholar
• Balkau B, Charles MA, Drivsholm T, et al Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab 2002;28:364–376
   PubMed Web of Science ®Google Scholar
• Ciampelli M, Leoni F, Cucinelli F, et al Assessment of insulin sensitivity from measurements in the fasting state and during an oral glucose tolerance test in polycystic ovary syndrome and menopausal patients. J Clin Endocrinol Metab 2005;90:1398–1406
   PubMed Web of Science ®Google Scholar
• Hutchison S, Zoungas S, Teede HJ. Insulin levels, insulin resistance and the use of metformin in polycystic ovary syndrome. Med J Aust 2007;186:268–269
   PubMedGoogle Scholar
• Cobin RH. Polycystic ovarian syndrome and insulin resistance: implications for estrogen use in premenopausal and postmenopausal women. Metab Syndr Relat Disord 2005;3:259–269
   PubMedGoogle Scholar
• Pasquali R, Gambineri A. Polycystic ovary syndrome: a multifaceted disease from adolescence to adult age. Ann NY Acad Sci 2006;1092:158–174
   PubMed Web of Science ®Google Scholar
• Teede H, Zoungas S, Deeks A, Farrell E, Moran L, Vollenhaven B. CHECK Independent Learning Program: Polycystic Ovarian Syndrome Royal Australian College of General Practitioners, March 2008, Unit 432
   Google Scholar
• Deeks A, Zoungas S, Teede H. Risk perception in women: a focus on menopause. Menopause 2008;15:304–309
   PubMed Web of Science ®Google Scholar
• Kaaks R, Lukanova A, Kurzer MS. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev 2002;11:1531–1543
   PubMed Web of Science ®Google Scholar
• Uharcek P. Prognostic factors in endometrial carcinoma. J Obstet Gynecol Res 2008;34:776–783
   Google Scholar
• Adderly-Kelly B, Williams-Stephens E. The relationship between obesity and breast cancer. ABNF J 2003;14:61–65
   PubMedGoogle Scholar
• Steiner E, Klubert D, Knuston D. Assessing breast cancer risk in women. Am Fam Physician 2008;78:1361–1366
   PubMed Web of Science ®Google Scholar
• Ferrara CM, Lynch NA, Nicklas BJ, Ryan AS, Berman DM. Differences in adipose tissue metabolism between postmenopausal and perimenopausal women. J Clin Endocrinol Metab 2002;87:4166–4170
   PubMed Web of Science ®Google Scholar
• Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 2003;88:2404–2411
   PubMed Web of Science ®Google Scholar
• Jones ME, Boon WC, Proietto J, Simpson ER. Of mice and men: the evolving phenotype of aromatase deficiency. Trends Endocrinol Metab 2006;17:55–64
   PubMed Web of Science ®Google Scholar
• Toth MJ, Tchernof A, Sites CK, Poehlman ET. Effect of menopausal status on body composition and abdominal fat distribution. Int J Obes Relat Metab Disord 2000;24:226–231
   PubMed Web of Science ®Google Scholar
• Poehlman ET, Toth MJ, Gardner AW. Changes in energy balance and body composition at menopause: a controlled longitudinal study. Ann Intern Med 1995;123:673–675
   PubMed Web of Science ®Google Scholar
• Svendsen OL, Haarbo J, Hassager C, Christiansen C. Accuracy of measurements of body composition by dualenergy x-ray absorptiometry in vivo. Am J Clin Nutr 1993;57:605–608
   PubMed Web of Science ®Google Scholar
• Pedersen SB, Bruun JM, Kristensen K, Richelsen B. Regulation of UCP1, UCP2, and UCP3 mRNA expression in brown adipose tissue, white adipose tissue, and skeletal muscle in rats by estrogen. Biochem Biophys Res Commun 2001;288:191–197
   PubMedGoogle Scholar
• Roy EJ, Wade GN. Role of estrogens in androgen-induced spontaneous activity in male rats. J Comp Physiol Psychol 1975;89:573–579
   PubMed Web of Science ®Google Scholar
• Heine PA, Taylor JA, Iwamoto GA, Lubahn DB, Cooke PS. Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc Natl Acad Sci USA 2000;97:12729–12734
   PubMed Web of Science ®Google Scholar
• Ravussin E, Lillioja S, Knowler WC, et al Reduced rate of energy expenditure as a risk factor for body-weight gain. N Engl J Med 1988;318:467–472
   PubMed Web of Science ®Google Scholar
• Misso M, Jang C, Adams J, et al Differential expression of factors involved in fat metabolism with age and the menopausal transition. Maturitas 2005;51:299–306
   PubMed Web of Science ®Google Scholar
• Razay G, Heaton KW, Bolton CH. Coronary heart disease risk factors in relation to the menopause. Q J Med 1992;85:889–896
   PubMedGoogle Scholar
• Dallongeville J, Marecaux N, Isorez D, Zylbergberg G, Fruchart JC, Amouyel P. Multiple coronary heart disease risk factors are associated with menopause and influenced by substitutive hormonal therapy in a cohort of French women. Atherosclerosis 1995;118:123–133
   PubMed Web of Science ®Google Scholar
• Lynch NA, Nicklas BJ, Berman DM, Dennis KE, Goldberg AP. Reductions in visceral fat during weight loss and walking are associated with improvements in VO(2 max). J Appl Physiol 2001;90:99–104
   PubMed Web of Science ®Google Scholar
• DeNino WF, Tchernof A, Dionne IJ, et al Contribution of abdominal adiposity to age-related differences in insulin sensitivity and plasma lipids in healthy nonobese women. Diabetes Care 2001;24:925–932
   PubMed Web of Science ®Google Scholar
• Guthrie JR, Ball M, Dudley EC, et al Impaired fasting glycaemia in middle-aged women: a prospective study. Int J Obes Relat Metab Disord 2001;25:646–651
   PubMed Web of Science ®Google Scholar
• Jones GL, Sutton A. Quality of life in obese postmenopausal women. Menopause Int 2008;14:26–32
   PubMedGoogle Scholar
• Wadden TA, Butryn ML, Sarwer DB, et al Comparison of psychosocial status in treatment-seeking women with class III vs. class I-II obesity. Obesity 2006;14(Suppl 2):90–98S
   Google Scholar
• Bradshaw A, Katzer L, Horwath CC, et al A randomised trial of three non-dieting programs for overweight women. Asia Pac J Clin Nutr 2004;13(Suppl):S43
   Google Scholar
• Teixeira PJ, Going SB, Houtkeeper LB, et al Pretreatment predictors of attrition and successful weight management in women. Int J Obes Relat Metab Disord 2004;28:1124–1133
   PubMed Web of Science ®Google Scholar
• Knowler W, Barrett Connor E, Fowler SE, et al Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393–403
   PubMed Web of Science ®Google Scholar
• Lemmens V, Oenema A, Klepp KI, Henriksen HB, Brug J. A systematic review of the evidence regarding efficacy of obesity prevention interventions among adults. Obesity Rev 2008;9:446–455
   PubMed Web of Science ®Google Scholar
• Lombard CB, Deeks AA, Ball K, Jolley D, Teede HJ. A systematic review of interventions aimed at prevention of weight gain in adults. Public Health Nutr 2009 Aug 4. Epub ahead of print
   Google Scholar
• Riddell LJ, Inman V. Body weight and weight loss: are health messages reaching their target. Asia Pac J Clin Nutr 2007;16:683–687
   PubMed Web of Science ®Google Scholar
• Lombard C, Deeks A, Ball K, Jolley D, Teede T. Weight, physical activity and dietary behaviour change in a population of young mothers: short term results of the HeLP-her cluster randomized controlled trial. Nutr J 2009;8:17
   PubMed Web of Science ®Google Scholar
• Mosca L, Ferris A, Fabunmi R, Robertson RM. Tracking women's awareness of heart disease: an American Heart Association national study. Circulation 2004;109:573–579
   PubMed Web of Science ®Google Scholar
• Teede HJ, Zoungas S, Hutchison S. The management of insulin resistance in PCOS. Trends Endocrinol Metab 2007;18:273–279
   PubMed Web of Science ®Google Scholar
• Lobo RA. Metabolic syndrome after menopause and the role of hormones. Maturitas 2008;60:10–18
   PubMed Web of Science ®Google Scholar
• Lobo RA. Menopause and stroke and the effects of hormonal therapy. Climacteric 2007; 10(Suppl 2):27–31
   PubMed Web of Science ®Google Scholar
• Augoulea A, Mastorakos G, Lambrinoudaki I, Christodoulakos G, Creatsas G. Role of postmenopausal hormone replacement therapy on body fat gain and leptin levels. Gynecol Endocrinol 2005;20:227–235
   PubMed Web of Science ®Google Scholar
• Salpeter SR, Walsh JM, Ormisotn TM, Greyber E, Buckley NS, Salpeter EE. Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women. Diabetes Obes Metab 2006;8:538–554
   PubMed Web of Science ®Google Scholar
• Greendale GA, Gold EB. Lifestyle factors: are they related to vasomotor symptoms and do they modify the effectiveness or side effects of hormone therapy. Am J Med 2005;118(Suppl 12B):148–154
   PubMedGoogle Scholar
• Cate Kongnyuy EJ, Norman RJ, Flight IHK, Rees MC. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution. Cochrane Database of Systematic Reviews 1999, Issue 3. Art. No.: CD001018. DOI: 10.1002/14651858.CD001018. Updated 2005
   Google Scholar
• Cameron AJ, Welborn TA, Zimmet PZ, et al Overweight and obesity in Australia: the 1999–2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Med J Aust 2003;178:427–432
   PubMed Web of Science ®Google Scholar